Effects of the GLP-1 analogue liraglutide on ectopic fat distribution and sex hormones in women with PCOS: a randomised, clinical trial

被引：0
|
作者：
Frossing, S. [1 ,2 ]
Nylander, M. [2 ,3 ]
Kistorp, C. [1 ,2 ]
Skouby, S. O. [2 ,3 ]
Faber, J. [1 ,2 ]
机构：
[1] Herlev Univ Hosp, Endocrine Unit, Internal Med, Copenhagen, Denmark
[2] Univ Copenhagen, Copenhagen, Denmark
[3] Herlev Univ Hosp, Gynecol & Obstet, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2016年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
806
引用
收藏
页码：S385 / S385
页数：1
相关论文
共 50 条
  • [1] Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)
    Femminella, Grazia Daniela
    Frangou, Eleni
    Love, Sharon B.
    Busza, Gail
    Holmes, Clive
    Ritchie, Craig
    Lawrence, Robert
    McFarlane, Brady
    Tadros, George
    Ridha, Basil H.
    Bannister, Carol
    Walker, Zuzana
    Archer, Hilary
    Coulthard, Elizabeth
    Underwood, Ben R.
    Prasanna, Aparna
    Koranteng, Paul
    Karim, Salman
    Junaid, Kehinde
    McGuinness, Bernadette
    Nilforooshan, Ramin
    Macharouthu, Ajay
    Donaldson, Andrew
    Thacker, Simon
    Russell, Gregor
    Malik, Naghma
    Mate, Vandana
    Knight, Lucy
    Kshemendran, Sajeev
    Harrison, John
    Brooks, David J.
    Passmore, Anthony Peter
    Ballard, Clive
    Edison, Paul
    TRIALS, 2019, 20 (1)
  • [2] Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
    Grazia Daniela Femminella
    Eleni Frangou
    Sharon B. Love
    Gail Busza
    Clive Holmes
    Craig Ritchie
    Robert Lawrence
    Brady McFarlane
    George Tadros
    Basil H. Ridha
    Carol Bannister
    Zuzana Walker
    Hilary Archer
    Elizabeth Coulthard
    Ben R. Underwood
    Aparna Prasanna
    Paul Koranteng
    Salman Karim
    Kehinde Junaid
    Bernadette McGuinness
    Ramin Nilforooshan
    Ajay Macharouthu
    Andrew Donaldson
    Simon Thacker
    Gregor Russell
    Naghma Malik
    Vandana Mate
    Lucy Knight
    Sajeev Kshemendran
    John Harrison
    David J. Brooks
    Anthony Peter Passmore
    Clive Ballard
    Paul Edison
    Trials, 20
  • [3] The GLP-1 analogue liraglutide: clinical profile in the light of registration trials results
    Consoli, A.
    GIORNALE DI GERONTOLOGIA, 2011, 59 (05) : 304 - 310
  • [4] Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
    Grazia Daniela Femminella
    Eleni Frangou
    Sharon B. Love
    Gail Busza
    Clive Holmes
    Craig Ritchie
    Robert Lawrence
    Brady McFarlane
    George Tadros
    Basil H. Ridha
    Carol Bannister
    Zuzana Walker
    Hilary Archer
    Elizabeth Coulthard
    Ben R. Underwood
    Aparna Prasanna
    Paul Koranteng
    Salman Karim
    Kehinde Junaid
    Bernadette McGuinness
    Ramin Nilforooshan
    Ajay Macharouthu
    Andrew Donaldson
    Simon Thacker
    Gregor Russell
    Naghma Malik
    Vandana Mate
    Lucy Knight
    Sajeev Kshemendran
    John Harrison
    Christian Hölscher
    David J. Brooks
    Anthony Peter Passmore
    Clive Ballard
    Paul Edison
    Trials, 21
  • [5] Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
    Russell-Jones, David
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 297 (1-2) : 137 - 140
  • [6] A COMPARISON OF THE EFFECTS OF THE GLP-1 ANALOGUE LIRAGLUTIDE AND INSULIN GLARGINE ON METABOLIC PARAMETERS AND ENDOTHELIAL FUNCTION
    Nomoto, H.
    Miyoshi, H.
    Nakamura, A.
    Manda, N.
    Kurihara, Y.
    Atsumi, T.
    Aoki, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S59 - S59
  • [7] Beneficial effects of Liraglutide, GLP-1 analogue, on cardiovascular risk factors in the type 2 diabetic
    Halimi, S.
    Lalanne, G.
    Ravaut, J. F.
    Reigneau, O.
    Dejager, S.
    DIABETES & METABOLISM, 2007, 33 : S18 - S18
  • [8] Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study) (vol 20, 191, 2019)
    Femminella, Grazia Daniela
    Frangou, Eleni
    Love, Sharon B.
    Busza, Gail
    Holmes, Clive
    Ritchie, Craig
    Lawrence, Robert
    McFarlane, Brady
    Tadros, George
    Ridha, Basil H.
    Bannister, Carol
    Walker, Zuzana
    Archer, Hilary
    Coulthard, Elizabeth
    Underwood, Ben R.
    Prasanna, Aparna
    Koranteng, Paul
    Karim, Salman
    Junaid, Kehinde
    McGuinness, Bernadette
    Nilforooshan, Ramin
    Macharouthu, Ajay
    Donaldson, Andrew
    Thacker, Simon
    Russell, Gregor
    Malik, Naghma
    Mate, Vandana
    Knight, Lucy
    Kshemendran, Sajeev
    Harrison, John
    Holscher, Christian
    Brooks, David J.
    Passmore, Anthony Peter
    Ballard, Clive
    Edison, Paul
    TRIALS, 2020, 21 (01)
  • [9] Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight
    Maria S. Svane
    Helle H. Johannesen
    Adam E. Hansen
    Christoffer Martinussen
    Kirstine N. Bojsen-Møller
    Martin Lundsgaard Hansen
    Carolyn F. Deacon
    Sune H. Keller
    Thomas L. Klausen
    Annika Loft
    Andreas Kjaer
    Johan Löfgren
    Sten Madsbad
    Jens J. Holst
    Nicolai J. Wewer Albrechtsen
    International Journal of Obesity, 2022, 46 : 2058 - 2062
  • [10] Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight
    Svane, Maria S.
    Johannesen, Helle H.
    Hansen, Adam E.
    Martinussen, Christoffer
    Bojsen-Moller, Kirstine N.
    Hansen, Martin Lundsgaard
    Deacon, Carolyn F.
    Keller, Sune H.
    Klausen, Thomas L.
    Loft, Annika
    Kjaer, Andreas
    Lofgren, Johan
    Madsbad, Sten
    Holst, Jens J.
    Albrechtsen, Nicolai J. Wewer
    INTERNATIONAL JOURNAL OF OBESITY, 2022, 46 (11) : 2058 - 2062
12345